Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio. (Q39125887)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 July 2013

Language	Label	Description	Also known as
English	Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio.	scientific article published on 13 July 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Md Golam Sharoar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Md Shahnawaz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Song Yub Shin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Il-Seon Park

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

13 July 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Journal of Peptide Science

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

545-553

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Dendritic changes in Alzheimer's disease and factors that may underlie these changes

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Alzheimer's disease. In the beginning...

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

New clues to Alzheimer's disease: unraveling the roles of amyloid and tau.

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Structural classification of toxic amyloid oligomers

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Annular protofibrils are a structurally and functionally distinct type of amyloid oligomer

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Fibrillar oligomers nucleate the oligomerization of monomeric amyloid beta but do not seed fibril formation

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Amyloid beta-peptide is produced by cultured cells during normal metabolism

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Abeta42 is essential for parenchymal and vascular amyloid deposition in mice

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Interaction between A beta(1-42) and A beta(1-40) in Alzheimer's beta-amyloid fibril formation in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Synthesis, aggregation, neurotoxicity, and secondary structure of various A beta 1-42 mutants of familial Alzheimer's disease at positions 21-23.

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Flemish and Dutch mutations in amyloid beta precursor protein have different effects on amyloid beta secretion

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

In vitro studies of Flemish, Dutch, and wild-type beta-amyloid provide evidence for two-staged neurotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Stable activity of a deubiquitylating enzyme (Usp2-cc) in the presence of high concentrations of urea and its application to purify aggregation-prone peptides

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo

1 reference

https://api.crossref.org/works/10.1002%2FPSC.2531

21 January 2018

Identifiers

10.1002/PSC.2531

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23853087%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39125887&oldid=1449234234"